Southern Acids (M) Berhad, an investment holding company, engages in the manufacture and trading of oleochemical products in Malaysia, Indonesia, Asia, Europe, the United States, and internationally. The company operates through four segments: Oleochemical Manufacturing, Milling & Cultivation, Investments & Services, and Healthcare Services. It offers fatty acids and glycerine for use in various applications, including personal care, cleaning agents, cosmetic, pharmaceutical, and food products. It is also involved in the processing of fresh fruit bunches into crude palm oil and palm kernel, as well as oil palm cultivation activities. In addition, it operates private hospital in Klang for the provision of cardiology, hand and microsurgery, nephrology, neurosurgery, orthopaedic surgery, obstetrics and gynaecology, radiotherapy, oncology services, cancer, fertility, cardiac care, and E.N.T. head and neck surgery. Further, it provides plantation; administrative; overhead conveyor goods loading services; warehousing; and port cargo handling, as well as develops properties and leases hospital building. Southern Acids (M) Berhad was incorporated in 1980 and is headquartered in Klang, Malaysia.
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
The market has been flat over the last week. As for the longer term, the market has also been flat over the past year. Earnings are forecast to grow by 9.9% annually. Market details ›